These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8881423)

  • 1. Effector mechanisms in demyelinating neuropathies.
    Hartung HP; Zielasek J; Jung S; Toyka KV
    Rev Neurol (Paris); 1996 May; 152(5):320-7. PubMed ID: 8881423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effector mechanisms of PNS demyelination in Gal-C induced-EAN].
    Saida K
    Rinsho Shinkeigaku; 1990 Dec; 30(12):1361-3. PubMed ID: 2129197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile.
    Dalakas MC
    Pharmacol Ther; 2004 Jun; 102(3):177-93. PubMed ID: 15246245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral mechanisms in immune neuropathies.
    Koski CL
    Neurol Clin; 1992 Aug; 10(3):629-49. PubMed ID: 1501599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology of inflammatory demyelinating neuropathies.
    Prineas JW
    Baillieres Clin Neurol; 1994 Apr; 3(1):1-24. PubMed ID: 7921584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory mediators in demyelinating disorders of the CNS and PNS.
    Hartung HP; Jung S; Stoll G; Zielasek J; Schmidt B; Archelos JJ; Toyka KV
    J Neuroimmunol; 1992 Oct; 40(2-3):197-210. PubMed ID: 1331168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in the understanding of the immunological basis of peripheral neuropathies.
    Larner AJ
    Br J Clin Pract; 1993; 47(5):262-5. PubMed ID: 8292474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental allergic neuritis (EAN) as a model for the immune-mediated demyelinating neuropathies.
    Hahn AF
    Rev Neurol (Paris); 1996 May; 152(5):328-32. PubMed ID: 8881424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effector mechanisms in anti-MAG antibody-mediated and other demyelinating neuropathies.
    Latov N; Renaud S
    J Neurol Sci; 2004 May; 220(1-2):127-9. PubMed ID: 15140620
    [No Abstract]   [Full Text] [Related]  

  • 10. Demyelinating inflammatory neuropathies, including Guillain-Barré syndrome.
    Steck AJ; Schaeren-Wiemers N; Hartung HP
    Curr Opin Neurol; 1998 Aug; 11(4):311-8. PubMed ID: 9725076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis.
    Dittel BN
    Arch Immunol Ther Exp (Warsz); 2000; 48(5):381-8. PubMed ID: 11140465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies.
    Koski CL; Sanders ME; Swoveland PT; Lawley TJ; Shin ML; Frank MM; Joiner KA
    J Clin Invest; 1987 Nov; 80(5):1492-7. PubMed ID: 3680509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunopathology of inflammatory neuropathies].
    Oka N
    Rinsho Shinkeigaku; 1999 Jan; 39(1):90-1. PubMed ID: 10377818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiglycolipid antibodies in Guillain-Barré syndrome and related diseases: review of clinical features and antibody specificities.
    Ariga T; Yu RK
    J Neurosci Res; 2005 Apr; 80(1):1-17. PubMed ID: 15668908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simulating focal demyelinating neuropathies: membrane property abnormalities.
    Stephanova DI; Alexandrov AS; Kossev A; Christova L
    Biol Cybern; 2007 Feb; 96(2):195-208. PubMed ID: 17072638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acquired demyelinating neuropathies].
    Hahn AF
    Rev Prat; 2000 Apr; 50(7):724-30. PubMed ID: 10853551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiganglioside antibodies in the pathogenesis of autoimmune neuropathies].
    Kusunoki S
    Rinsho Shinkeigaku; 1999 Jan; 39(1):93-5. PubMed ID: 10377820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory neuropathy: pathogenesis and clinical features.
    Steck AJ
    Curr Opin Neurol Neurosurg; 1992 Oct; 5(5):633-7. PubMed ID: 1392137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of complement in autoimmune thyroid disorders].
    Potluková E; Limanová Z
    Cas Lek Cesk; 2007; 146(3):210-4. PubMed ID: 17419301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies.
    Zhang G; Lopez PH; Li CY; Mehta NR; Griffin JW; Schnaar RL; Sheikh KA
    Brain; 2004 May; 127(Pt 5):1085-100. PubMed ID: 14985267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.